Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?
Reproductive BioMedicine Online · 2026-07 · 53 (1) · 105546
DOI: 10.1016/j.rbmo.2026.105546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026-07. Verfasst von Caroline Roelens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brussels IVF, UZ Brussel, Brussels, Belgium.. Electronic address: caroline.roelens@uzbrussel.be. Hauptthemen laut MEDLINE: Dydrogesterone, Embryo Transfer, Progesterone, Progestins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: Is oral dydrogesterone administration associated with comparable pregnancy rates when suboptimal serum progesterone concentrations are identified on the day of transfer in true and modified natural-cycle frozen embryo transfer (NC-FET)? DESIGN: This retrospective study, conducted at a tertiary university-based referral centre, included 886 patients undergoing NC-FET without luteal phase support before FET who had serum progesterone measured on the day of transfer. Patients with serum progesterone
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brussels IVF, UZ Brussel, Brussels, Belgium.. Electronic address: caroline.roelens@uzbrussel.be.
- Brussels IVF, UZ Brussel, Brussels, Belgium.
- Department of Obstetrics and Gynecology, Memorial Bahcelievler Hospital, Istanbul, Turkey.
- Brussels IVF, UZ Brussel, Brussels, Belgium.; Research Group Genetics Reproduction and Development (GRAD), Vrije Universiteit Brussel, Brussels, Belgium.
Zitieren
APA
Roelens, C., Van Overberghe, C., Aktoz, F., Van Landuyt, L., Mackens, S., De Vos, M., Tournaye, H., & Blockeel, C. (2026). Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?. Reproductive BioMedicine Online, 53(1), 105546. https://doi.org/10.1016/j.rbmo.2026.105546
Vancouver
Roelens C, Van Overberghe C, Aktoz F, Van Landuyt L, Mackens S, De Vos M, et al. Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?. Reproductive BioMedicine Online. 2026;53(1):105546. doi:10.1016/j.rbmo.2026.105546
BibTeX
@article{Roelens2026,
author = {Roelens, Caroline and Van Overberghe, Charlotte and Aktoz, Fatih and Van Landuyt, Lisbet and Mackens, Shari and De Vos, Michel and Tournaye, Herman and Blockeel, Christophe},
title = {Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?},
journal = {Reproductive BioMedicine Online},
year = {2026},
volume = {53},
number = {1},
pages = {105546},
doi = {10.1016/j.rbmo.2026.105546}
}
EUVIMED